In line with previous findings of the oncogenic role of METTL3 in CRC, we unveiled that METTL3 was remarkably upregulated in CRC tissues, cell lines, and plasma samples and promoted CRC cell proliferation, migration, and metastasis thus contributing to CRC progression (Fig. 7). The gene discussed is METTL3; the disease is colorectal carcinoma.